Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Lisinopril vs Combination in Renal Disease
NCT00171574Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valsartan in chronic kidney disease (CKD), diabetic nephropathy (DN) and hypertension (HTN) (3 arms), sponsored by Novartis. Primary endpoint: Change from baseline in urine protein excretion at 20 weeks. Started Nov 2004; status: completed.
02
Drugs
valsartan
03
Conditions
chronic kidney disease (CKD)diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT00171574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171574.